Roza Chaireti

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: PHARMACEUTICALS. 2025;18(7):1044
Discrepancies in Recommendations on Pharmacokinetic Drug Interactions for Anticancer Medications and Direct Oral Anticoagulants (DOAC): A Comparative Analysis of Different Clinical Decision Support Systems and Sources
Nowinski K; Chaireti R
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2025;:S1538-7836(25)00138-2
Hereditary antithrombin deficiency and venous thrombosis in pregnancy-results of a retrospective multicenter study.
Dybedal I; Iversen N; Jacobsen AF; Bjørge L; Chaireti R; Henriksson CE; Schultz NH; Hvas AM; Sandset PM; Weedon-Fekjær H; Bremme K; Abildgaard U
Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2024;33(5):580-587
Identification of biallelic POLA2 variants in two families with an autosomal recessive telomere biology disorder
Kvarnung M; Pettersson M; Chun-on P; Rafati M; Mcreynolds LJ; Norberg A; Moura PL; Pesonen I; Chaireti R; Soderholm BG; Burlin J; Ryden J; Lindberg EH; Giri N; Savage SA; Agarwal S; Nordgren A; Tesi B
Article: CANCERS. 2024;16(14):2511
Incidence and Risk Factors for Arterial Thrombosis in Patients with Acute Leukemia and Lymphoid Malignancies: A Retrospective Single-Center Study
Hellman J; Chaireti R
Article: CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS. 2024;30:10760296241260053
Global Hemostatic Methods to Tailor Treatment With Bypassing Agents in Hemophilia A With Inhibitors-A Single-Center, Pilot Study
Chaireti R; Soutari N; Holmstrom M; Petrini P; Magnusson M; Ranta S; Pruner I; Antovic JP
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2023;201(2):326-333
Acquired Haemophilia A in four north European countries: survey of 181 patients
Lindahl R; Nummi V; Lehtinen A-E; Szanto T; Hiltunen L; Olsson A; Glenthoej A; Chaireti R; Vaide I; Funding E; Zetterberg E
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2022;109(6):749-754
Conditioning with melphalan 200 mg/m² and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care
Afram G; Chaireti R; Uttervall K; Luong V; Lund J; Kashif M; Gahrton G; Alici E; Nahi H
Journal article: HEMATO. 2022;3(3):518-526
Risk Factors and Risk Stratification of Thromboembolic Risk in Patients with Multiple Myeloma
Chaireti R; Nahi H; Mazzucato M
Article: LUPUS. 2021;30(7):1031-1038
The presence of lupus nephritis additionally increases the risk of preeclampsia among pregnant women with systemic lupus erythematosus
Bremme K; Honkanen S; Gunnarsson I; Chaireti R
Article: JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE. 2021;34(10):1641-1644
Obstetric and neonatal outcomes in pregnant women treated with high-dose thromboprophylaxis: a retrospective, single-center study
Bremme K; Lannemyr A; Tyni L; Chaireti R
Article: THROMBOSIS AND HAEMOSTASIS. 2021;121(01):27-35
Genetics and Hemostatic Potential in Persons with Mild to Moderate Hemophilia A with a Discrepancy between One-Stage and Chromogenic FVIII Assays
Stralfors A; Mikovic D; Schmidt D; Onelov L; Soutari NMH; Berndtson M; Chaireti R; Holmstrom M; Antovic JP; Bruzelius M
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2020;18(10):2582-2589
Management and outcomes of newborns at risk for inherited antithrombin deficiency
Chaireti R; Tronnhagen I; Bremme K; Ranta S
Article: SCIENTIFIC REPORTS. 2020;10(1):7871
Phosphatidylserine positive microparticles improve hemostasis in in-vitro hemophilia A plasma models
Zong Y; Pruner I; Antovic A; Taxiarchis A; Vila ZP; Soutari N; Mobarrez F; Chaireti R; Widengren J; Piguet J; Antovic JP
Article: JOURNAL OF ELECTROCARDIOLOGY. 2020;58:171-175
Substantial prevalence of subclinical cardiovascular diseases in patients with hemophilia A evaluated by advanced electrocardiography
Zong Y; Maanja M; Chaireti R; Schlegel TT; Ugander M; Antovic JP
Article: THROMBOSIS RESEARCH. 2019;178:34-40
Correlation of thromboelastography and thrombin generation assays in warfarin-treated patients
Schmidt DE; Chaireti R; Bruzelius M; Holmstrom M; Antovic J; Agren A
Article: LUPUS. 2019;28(7):868-877
Obstetric outcomes in patients with primary thrombotic and obstetric antiphospholipid syndrome and its relation to the antiphospholipid antibody profile
Hogden A; Antovic A; Berg E; Bremme K; Chaireti R
Article: HAEMOPHILIA. 2019;25(2):334-342
Evaluation of a standardized protocol for thrombin generation using the calibrated automated thrombogram: A Nordic study
Ljungkvist M; Strandberg K; Berntorp E; Chaireti R; Holme PA; Larsen OH; Lassila R; Jouppila A; Szanto T; Zetterberg E
Article: PLOS ONE. 2019;14(1):e0210544
Blood inflammatory and endothelial markers in women with von Willebrand disease
Govorov I; Bremme K; Larsson A; Holmstrom M; Komlichenko E; Chaireti R; Mints M
Article: SCIENTIFIC REPORTS. 2018;8(1):17467
Thrombin generation during a regular menstrual cycle in women with von Willebrand disease
Govorov I; Bremme K; Lindahl TL; Holmstrom M; Komlichenko E; Chaireti R; Mints M
Article: BLOOD. 2017;130(15):1706-1712
Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study
Majeed A; Agren A; Holmstrom M; Bruzelius M; Chaireti R; Odeberg J; Hempel E-L; Magnusson M; Frisk T; Schulman S
Article: EXPERIMENTAL AND THERAPEUTIC MEDICINE. 2016;11(5):1923-1929
Heavy menstrual bleeding and health-associated quality of life in women with von Willebrand's disease
Govorov I; Ekelund L; Chaireti R; Elfvinge P; Holmstrom M; Bremme K; Mints M
Article: SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION. 2016;76(3):190-194
Inflammatory and endothelial markers during the menstrual cycle
Chaireti R; Lindahl TL; Bystrom B; Bremme K; Larsson A
Article: PLOS ONE. 2016;11(10):e0164683
Postpartum Hemorrhage in Women with Von Willebrand Disease - A Retrospective Observational Study
Govorov I; Lofgren S; Chaireti R; Holmstrom M; Bremme K; Mints M
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2015;94(4):355-362
TP53 mutations and MDM2^SNP309 identify subgroups of AML patients with impaired outcome
Falk IJ; Willander K; Chaireti R; Lund J; Nahi H; Hermanson M; Green H; Lotfi K; Soderkvist P
Journal article: JOURNAL OF HEMATOLOGY. 2015;4(3):202-204
Management of a Patient With Subdural Hematoma Complicated by the Presence of Heparin-Induced and Suspected Concomitant Immune Thrombocytopenia: A Case Report
Chaireti R; Gkasiamis A; Lindahl TL
Article: THROMBOSIS RESEARCH. 2014;134(2):455-461
Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event
Chaireti R; Rajani R; Bergquist A; Melin T; Friis-Liby I-L; Kapraali M; Kechagias S; Lindahl TL; Almer S
Article: BIOMARKER RESEARCH. 2014;2:18
Mutations in the isocitrate dehydrogenase 2 gene and IDH1 SNP 105C > T have a prognostic value in acute myeloid leukemia
Willander K; Falk IJ; Chaireti R; Paul E; Hermansson M; Green H; Lotfi K; Soderkvist P
Article: HUMAN REPRODUCTION. 2013;28(7):1846-1852
Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle
Chaireti R; Gustafsson KM; Bystrom B; Bremme K; Lindahl TL
Article: THROMBOSIS RESEARCH. 2013;131(2):135-139
Is thrombin generation at the time of an acute thromboembolic episode a predictor of recurrence? The LInkoping Study on Thrombosis (LIST) - A 7-year follow-up
Chaireti R; Jennersjo C; Lindahl TL
Article: THROMBOSIS RESEARCH. 2009;124(2):178-184
Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study
Chaireti R; Jennersjo C; Lindahl TL
Article: DIGESTIVE DISEASES AND SCIENCES. 2007;52(9):2351-2358
Effect of 5-HT₂ receptor blockade on cadmium-induced acute toxicity
Tzirogiannis KN; Demonakou MD; Papadimas GK; Skaltsas SD; Manta GA; Kourentzi KT; Alexandropoulou KN; Hereti RI; Mykoniatis MG; Panoutsopoulos GI
Article: DIGESTIVE DISEASES AND SCIENCES. 2006;51(11):1998-2006
Peliosis hepatis: Microscopic and macroscopic type, time pattern, and correlation with liver cell apoptosis in a model of toxic liver injury
Tzirogiannis KN; Papadimas GK; Kondyli VG; Kourentzi KT; Demonakou MD; Kyriakou LG; Mykoniatis MG; Hereti RI; Panoutsopoulos GI
Article: LIVER INTERNATIONAL. 2006;26(3):352-361
Effect of serotonin receptor 2 blockage on liver regeneration after partial hepatectomy in the rat liver
Papadimas GK; Tzirogiannis KN; Panoutsopoulos GI; Demonakou MD; Skaltsas SD; Hereti RI; Papadopoulou-Daifoti Z; Mykoniatis MG
Article: IN VIVO. 2005;19(5):841-847
The effect of hepatic stimulator substance (HSS) on liver regeneration arrest induced by 5-HT₂ receptor blockade
Tzirogiannis KN; Panoutsopoulos GI; Papadimas GK; Demonakou MD; Hereti RI; Manta GA; Kourentzi KT; Kondili VG; Alexandropoulou KN; Mykoniatis MG
Article: IN VIVO. 2005;19(4):695-704
The role of hepatic stimulator substance (HSS) on liver regeneration arrest induced by cadmium
Tzirogiannis KN; Papadimas GK; Kourentzi KT; Kondili VG; Androutsos CD; Hereti RI; Triantaphyllou MI; Panoutsopoulos GI
Article: DIGESTIVE DISEASES AND SCIENCES. 2005;50(2):297-307
The hepatoprotective effect of hepatic stimulator substance (HSS) against liver regeneration arrest induced by acute ethanol intoxication
Kondili VG; Tzirogiannis KN; Androutsos CD; Papadimas GK; Demonakou MD; Hereti RI; Manta GA; Kourentzi KT; Triantaphyllou MI; Panoutsopoulos GI
Article: DIGESTIVE DISEASES AND SCIENCES. 2004;49(6):1019-1028
Effect of hepatic stimulator substance (HSS) on cadmium-induced acute hepatotoxicity in the rat liver
Tzirogiannis KN; Panoutsopoulos GI; Demonakou MD; Hereti RI; Alexandropoulou KN; Mykoniatis MG
Article: ARCHIVES OF TOXICOLOGY. 2004;78(6):321-329
The hepatoprotective effect of putrescine against cadmium-induced acute liver injury
Tzirogiannis KN; Panoutsopoulos GI; Demonakou MD; Papadimas GK; Kondyli VG; Kourentzi KT; Hereti RI; Mykoniatis MG
Article: ARCHIVES OF TOXICOLOGY. 2003;77(12):694-701
Time-course of cadmium-induced acute hepatotoxicity in the rat liver: the role of apoptosis
Tzirogiannis KN; Panoutsopoulos GI; Demonakou MD; Hereti RI; Alexandropoulou KN; Basayannis AC; Mykoniatis MG
Visa fler

Anställningar

Adjungerad Lektor, Molekylär medicin och kirurgi, Karolinska Institutet, 2024-2026
Adjungerad Lektor, Medicin, Solna, Karolinska Institutet, 2022-2026

Examina och utbildning

Docent, Hematologi, Karolinska Institutet, 2021

Artiklar

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI